Osaic Holdings’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.9K Buy
2,273
+9
+0.4% +$51 ﹤0.01% 5615
2025
Q1
$10.3K Sell
2,264
-376
-14% -$1.72K ﹤0.01% 5716
2024
Q4
$14.9K Sell
2,640
-25
-0.9% -$141 ﹤0.01% 5487
2024
Q3
$12.9K Buy
2,665
+141
+6% +$682 ﹤0.01% 5597
2024
Q2
$12.3K Sell
2,524
-107
-4% -$522 ﹤0.01% 5590
2024
Q1
$34.9K Buy
2,631
+726
+38% +$9.64K ﹤0.01% 4963
2023
Q4
$26.6K Sell
1,905
-2,086
-52% -$29.1K ﹤0.01% 5318
2023
Q3
$52.9K Buy
3,991
+3,041
+320% +$40.3K ﹤0.01% 4961
2023
Q2
$17.8K Sell
950
-14
-1% -$262 ﹤0.01% 5625
2023
Q1
$13.9K Sell
964
-173
-15% -$2.49K ﹤0.01% 5757
2022
Q4
$22K Sell
1,137
-1,136
-50% -$22K ﹤0.01% 5488
2022
Q3
$78K Buy
2,273
+1,773
+355% +$60.8K ﹤0.01% 4571
2022
Q2
$8K Buy
+500
New +$8K ﹤0.01% 6228
2022
Q1
Sell
-26
Closed 7291
2021
Q4
$0 Buy
+26
New ﹤0.01% 7381